throbber
Gene, 85 (1989) 553-557
`Elsevier
`
`GENE 03344
`
`553
`
`Growth at sub-optimal temperatures allows the production of functional, antigen-binding Fab frag(cid:173)
`ments in Escherichia coli
`
`(Carcinoembryonic antigen; inclusion bodies; recombinant antibody; recombinant DNA)
`
`Shmuel Cabilly
`
`Department of Biology, Technion -
`
`Israel Institute of Technology, Technion City, Haifa 32000 (Israel)
`
`Received by A.D. Riggs: May 8 1989
`Revised: July 17 1989
`Accepted: August 3 1989
`
`SUMMARY
`
`Expression in Escherichia coli of recombinant genes coding for the K-chain and the Fd fragment of an
`antibody directed against carcinoembryonic antigen gives rise to Fab dimers. These Fab fragments possess
`antibody activity, as demonstrated by enzyme-linked immunosorbent assay as well as by ligand competition
`assay. Effective production of soluble Fab in Escherichia coli was achieved by a decrease in the growth
`temperature. Following a one step purification by anion exchange chromatography, the bacterially-produced
`Fab retains its activity at 4 o C for at least two months. The relatively simple methodology described in this study
`should be useful for the design and production of antibodies in bacteria.
`
`INTRODUCTION
`
`Genetic engineering provides a means for the
`manipulation of antibody (Ab) structure and specifi(cid:173)
`city. Several forms of recombinant Abs have been
`constructed:
`human/mouse
`chimeric
`Abs
`(Boulianne et al., 1984), enzyme-linked Fab frag(cid:173)
`ments (Neuberger et al., 1984), Fv fragments (Skerra
`and Fluckthun, 1988) and 'single chain antibodies'
`(Bird et al., 1988; Huston et al., 1988). Recombinant
`
`Ab genes have been expressed in Escherichia coli
`(Boss et al., 1984; Cabilly et al., 1984), in yeast
`(Horwitz et al., 1988) and in mammalian lymphoid
`cells (Neuberger et al., 1984). Even though lympho(cid:173)
`cytes are naturally adapted for Ab production, bacte(cid:173)
`ria have potential advantages in terms of recom(cid:173)
`binant gene manipulations, growth, handling and
`economy. However,
`immunoglobulin (Ig) poly(cid:173)
`peptides precipitate in the bacterial cytoplasm as
`inclusion bodies, and solubilization of these bodies
`
`Co"espondence to: Dr. S. Cabilly, Department of Chemical
`Immunology, Weizmann Institute of Science, 76100 Rehovot
`(Israel) Tel. (08)482111; Fax (08)466966.
`
`Abbreviations: Ab, antibody; Ag, antigen; B-Fab, bacterially(cid:173)
`produced Fab; BSA, bovine serum albumin; CEA, carcino(cid:173)
`embryonic antigen; DE-52, diethylaminoethyl-cellulose; EIA,
`enzyme immunoassay; Fab, antigen-binding fragment; Fd, trun-
`
`cated heavy chain; Fd', gene encoding Fd; lg, immunoglobulin;
`k, gene encoding K chain; Fv, variable region fragment; PBS(cid:173)
`NP40, 0.15 M Na0/0.01 M Na ·phosphate pH 7.2/0.05% (v/v)
`Nonidet-P40; PMSF, phenylmethylsulfonyl fluoride; RBS, ribo(cid:173)
`some-binding site; PAGE, polyacrylamide gel electrophoresis;
`SDS, sodium dodecyl sulfate; TS buffer, 10 mM Tris-HO
`pH 8/150 mM Na0/0.05% (v/v) Nonidet-P40; v region, variable
`region.
`
`0378-1119/89/$03.50 © 1989 Elsevier Science Publishers B.V. (Biomedical Division)
`
`BEQ 1032
`Page 1
`
`

`
`554
`
`has required the use of chaotrophic agents followed
`by renaturation procedures. These procedures give
`very poor yields of Ab activity (Boss et al., 1984;
`Cabilly et al., 1984 ). Recently it was reported that the
`introduction of a bacterial signal sequence into
`Ig-encoding genes promotes the secretion of active
`Fab or Fv fragments (Better et al., 1988; Skerra and
`Fluckthun, 1988).
`I here report that in E. coli cells growing at 21 oc,
`a single expression plasmid coding for 1e-chains and
`truncated heavy chains (Fd fragments) gives rise to
`high yields of functional Fab fragments.
`
`EXPERIMENTAL AND DISCUSSION
`
`(a) Expression of soluble Fab-fragments in the
`Escherichia coli cytoplasm
`
`In an earlier study (Cabilly et al., 1984), we con(cid:173)
`structed expression vectors for ~e-chains and Fd
`fragments. The signal peptide coding sequence of
`each of the Ig genes was replaced by an ATG start
`codon and, as a result, Ig products accumulated in
`the E. coli cytoplasm. To obtain co-expression of
`both 1e-chain and Fd fragments, E. coli cells were
`co-transformed by two expression plasmids each
`carrying a different selection marker. However, no
`control could be established over the relative amount
`of each plasmid within individual cells. For this
`reason, and due to the possibility that translation of
`the two polypeptides from the same mRN A might
`improve their chance for proper assembly, a single
`plasmid harboring both genes in one transcription
`unit was constructed. Details of the plasmid, marked
`pFabCEA, are presented in Fig. 1.
`Transformants carrying pFabCEA expressed
`both K-chains and Fd fragments (Fig. 2A; note that
`the relative intensities of the two bands might be
`affected by the differential sensitivity of the lg poly(cid:173)
`peptides to detection by rabbit anti-mouse IgG;
`Cabilly et al., 1984 ). The amounts of soluble Ig poly(cid:173)
`peptides in E. coli transformants growing at three
`different temperatures (37, 30 and 21 oq were com(cid:173)
`pared. Relative band density ofimmunoblots (Fig. 3,
`lanes 4-6) show that the amount of soluble lg poly(cid:173)
`peptides is about ten-fold higher in cells growing at
`21 or 30°C as compared to cells grown at 37°C. In
`
`Fig. 1. Structure of the "and Fd expression vector pFabCEA.
`Two previously described expression plasmids (Cabilly et al.,
`1984), pkCEAtrp 207-1* and pyFd'CEAtrp 207-1* were used to
`construct a single transcription unit gene encoding the K-chain
`(k) and the Fd-fragment (Fd'). A Hpal-Sa/I fragment which
`contains the Fd gene was isolated from the yFd'CEA 207-1*
`plasmid and inserted into the K-chain expression vector
`pkCEAtrp 207-1*. The latter vector was linearized with EcoRI,
`followed by filling in 5' overhangs using Klenow polymerase and
`digestion with Sail. That way, the k and Fd' genes were succes(cid:173)
`sively positioned under the control of the trp promoter. Each of
`these genes is preceded by the trp RBS and the distance from
`k-gene termination codon to the RBS of Fd gene is 45 bp. Plas(cid:173)
`mids were prepared and propagated in the E. coli strain HB 101
`(recA 1, endA 1 ).
`
`addition, at the lower temperatures, a significantly
`higher amount of insoluble Igs was also observed
`(Fig. 3).
`Ig polypeptides from the soluble fraction of cul(cid:173)
`tures grown at 21 oc were purified on a DE-52
`column and analysed by non-reducing SDS-PAGE.
`Several bands were detected when the blotted
`membrane was reacted with rabbit anti-mouse lgG
`(Fig. 2B). The broad band at about 47 kDa repre(cid:173)
`sents two nearly overlapping bands (lanes 1, 2).
`These bands correspond in size to Ig dimers. The
`predicted Mr of a ~ejFd dimer is 47 508 and that of
`a K-chain dimer is 46 483. It therefore seems that the
`lower of the two high Mr bands is a ~e-chain dimer,
`whereas the higher one is a ~e/Fd dimer. The Ig
`preparation contains additional lower Mr bands.
`These bands represent either monomers or non(cid:173)
`covalent dimers which dissociate in the presence of
`SDS. In bacteria producing ~e-chain only, a band
`which probably represents ~e-chain dimers was de(cid:173)
`tected (lane 3).
`
`BEQ 1032
`Page 2
`
`

`
`3
`
`kDa
`
`-48 •
`
`-26
`
`1
`
`2
`
`t
`
`8
`
`A
`
`1 2 3 4
`
`5 6
`
`•
`
`555
`
`kDa
`
`-26
`-24
`
`Fig. 2. Immunoblot of B-Fab under reducing and non-reducing
`conditions. Panel A: analysis of Igs from B-Fab-producing cells
`under reducing conditions. Panel B: non reducing gel. Lane 1, Ig(cid:173)
`polypeptides from Fab-producing bacteria; lane 2, a preparation
`(the same as in lane 1) that has been further purified by affinity
`chromatography on anti-mouse IgG-agarose; lane 3, a prepara(cid:173)
`tion from K-chain-producing bacteria. Transformants of the
`E. coli strain W31l0, AE2 tonB-trpE, were grown at 21 oc in M9
`medium supplemented with 4% L broth to a cell density of
`A 550 = 1.0. The harvested cell pellet from a 1 liter culture was
`suspended in 5 ml of disruption buffer containing 20 mM Tris(cid:173)
`HQ, pH 8, 20 mM EDT A, 1 mM PMSF and 1 mM leupeptin,
`disrupted by a French Pressure Cell, and centrifuged at
`40000 x g for 30 min. The supernatant was dialysed against
`20 mM Tris · HCl, pH 8, 5 mM NaCl, and purified by two con(cid:173)
`secutive runs on a DE-52 column (5 ml, Whatman) pre(cid:173)
`equilibrated and eluted with the same buffer. The first 10 ml of
`unbound material was collected, concentrated to 1.5 ml and dia(cid:173)
`lysed against TS buffer. Samples representing 1 ml bacteria,
`A 550 = 1.0 were separated on O.l%SDS-12% PAGE, and the
`proteins transferred to nitrocellulose membranes (Schleicher &
`Schuell, BA 83). The membranes were blocked with 1% BSA in
`TS buffer, incubated with affinity purified rabbit anti mouse IgG
`( 1 : 1000) for 1 h at 3 7 o C, washed three times for I 0 min with TS
`buffer, incubated with 1:1000 dilution of goat anti-rabbit IgG
`alkaline phosphatase conjugate for 1 h, and washed again with
`TS buffer. The bands were visualized by the method of Leary
`et al. (1983).
`
`(b) Ag binding by bacterially-produced Fab
`
`DE-52-purified lgs from E. coli extracts were
`analysed for Ag (CEA) binding by EIA. As shown
`in Fig. 4, B-Fab binds to CEA in a saturable manner.
`In contrast to B-Fab, no Ag binding was detected
`when either K-chains or Fd-fragments, were analysed
`under the same conditions (Fig. 4 ). The specificity of
`B-Fab is also demonstrated by its ability to compete
`for the binding of hybridoma-produced 1251-anti(cid:173)
`CEA to the antigen (Fig. 5). This demonstrates that
`
`Fig. 3. Expression of lg polypeptide in E. coli as a function of the
`growth temperature. Bacteria ( 10 ml) were grown to a cell density
`of A 550 = 1.5. The cell pellet was suspended in 1 ml disruption
`buffer (see Fig. 2) containing 1 mg lysosyme and incubated for
`30 min. at 4°C. Following freezing and thawing four times,
`cellular DNA was fragmented by shearing through a 27-gage
`syringe needle and the lysate centrifuged for 15 min in an
`Eppendorf centrifuge at 4 o C. One tenth of either the particulate
`on the soluble fractions was applied to 0.1% SDS-12% PAGE.
`Immunoblots were developed by alkaline phosphatase Ab con(cid:173)
`jugate as described in Fig. 2. The particulate fractions (lanes 1-3)
`and the soluble fractions (lanes 4-6) were derived from cultures
`grown at 37°C(Ianes 1,4), 30°C(lanes 2,5) and 2JOC (lanes 3,6).
`
`1 .50 . - - - - - - - - - - - - - - - . ,
`
`10
`
`E c:
`0 v
`<(
`
`1.00
`
`0.50
`
`0.00
`
`10
`100
`Dilutions of 8-Fab
`Fig. 4. A dose response curve ofB-Fab binding to CEA. Analysis
`was done by EIA. (e), B-Fab; T, purified extracts from bacteria
`producing either K-chain or Fd fragments (see Fig. 2). The
`amount oflg chains in the different 'non-diluted' DE-52 purified
`extracts was brought to about 3 Jlg/well.
`CEA (25 ng in 50 Ill of 0.1 M carbonate-bicarbonate buffer,
`pH 9.3) was dried at 37°C in wells of a polyvinylchloride micro(cid:173)
`titer plate and nonspecific sites were blocked with 2% BSA.
`Serial dilutions of lg purified from E. coli extracts were added
`and incubated for 90 min at 37°C, then washed extensively with
`phosphate-buffered saline containing 0.05% Nonidet-P40
`(PBS-NP40). Goat anti-mouse Fab-alkaline phosphatase con(cid:173)
`jugate was used to determine specific ligand binding. Parallel
`series of diluted lg preparations were incubated in the absence
`of antigen for background subtraction.
`
`BEQ 1032
`Page 3
`
`

`
`556
`
`the bacterially-produced Fab has the same antigen
`binding site as that of the monoclonal antibody from
`which it is was derived.
`On the basis of these results, the estimated amount
`of functional B-Fab obtained after DE-52 purifica(cid:173)
`tion from 1 ml of bacteria at A 550 = 1.0, is about
`100 ng. This amount is equivalent to 5-10% of the
`total protein in the DE-52 eluate or about 1.5 JJ.gfmg
`protein.
`The activity of the DE-52-purified B-Fab remained
`stable upon storage at 4 o C for more than two
`months.
`
`(c) Conclusions
`
`(1) This report shows that functional Fab frag(cid:173)
`ments can be obtained from extracts of E. coli trans(cid:173)
`formants.
`(2) The amount oflg polypeptides and its soluble
`fraction is much higher in E. coli cells growing at
`21 oc or 30°C rather than at 37°C.
`(3) The soluble Fab fragments isolated from
`E. coli appear as covalent dimers (Fig. 2B). It seems
`that in the highly reducing environment of the E. coli
`cytoplasm (Politt and Zalkin, 1983), the Ig poly(cid:173)
`peptides exist as non-covalently linked dimers, and
`
`;e
`
`0 -"0 c:
`
`:I
`0
`.0
`.0
`<X
`,.....,
`>-4
`It)
`
`~ ........
`
`100
`
`80
`
`60
`
`40
`
`20
`
`0
`
`1000
`
`10
`100
`8-Fob (ng)
`Fig. 5. Inhibition curve of 1251-labeled anti-CEA binding to CEA
`with B-Fab as inhibitor. Increasing amounts of DE-52 purified
`B-Fab were added together with 50 ng of 1251-anti-CEA (Johnson
`and Thorpe, 1982) to CEA precoated wells. Following incubation
`for 90 min, the wells were washed with PBS-NP40, cut out and
`taken for radioactive measurement in a gamma counter. The
`total amount of lg polypeptides in the DE-52 purified extracts
`(indicated as B-Fab on the abscissa) was estimated by scanning
`immunoblots which included standards of hybridoma-produced
`anti-CEA and were visualized by goat anti-mouse Fab-alkaline
`phosphatase conjugate.
`
`that the covalent dimers are formed by air oxidation
`following cell rupture.
`( 4) The Ig dimers seen in E. coli are not limited to
`pairs of K/Fd. Dimers of K-chains were seen in
`extracts of K-chain producing bacteria (Fig. 2B,
`lane 3) and Fd dimers were formed in Fd producing
`cells (unpublished data). However, the much higher
`association constant of K/Fd dimers compared to
`that of the homodimers (Darrington, 197 8 ), implies
`predominance of K/Fd dimers in cells producing
`equal amounts of both chains.
`(5) Since in the B-Fab expression plasmid the
`K-chain coding sequence is located upstream from
`the Fd fragments, an excess of K-chains may be
`expected. This would explain the apparent produc(cid:173)
`tion of K-chain dimers in Fab-producing cells
`(Fig. 2B).
`( 6) This method opens a route for
`in situ
`screening of E. coli colonies producing Fab frag(cid:173)
`ments with particular specificities.
`
`ACKNOWLEDGEMENT
`
`I thank Dr. D. Cassel, D. Sahar, N. Halachmi
`and R. Amit for valuable discussions. This research
`was supported by a grant from the Israel Cancer
`Research Fund and a grant from the Ministry of
`Commerce and Industry.
`
`Better, M., Chang, C.P., Robinson, R.R. and Horwitz, A.H.:
`E. coli secretion of an active chimeric antibody fragment.
`Science 240 (1988) 1041-1043.
`Bird, R.E., Hardman, K.D., Jacobson, J.W., Johnson, S.,
`Kaufman, B.M., Lee, S., Lee, T., Hope, S.H., Riordan, G.S.
`and Whitlow, M.: Single chain antigen-binding proteins.
`Science 242 (1988) 423-426.
`Boss, M.A., Kenten, J.H., Wood, C.R. and Emtage, J.S.:
`Assembly of functional antibodies from immunoglobulin
`heavy and light chains synthesized in E. coli. Nucleic Acids
`Res. 12 (1984) 3791-3806.
`Boulianne, G.L., Hozumi, N. and Shulman, M.J.: Production of
`functional chimaeric mouse/human antibody. Nature 312
`( 1984) 643-646.
`Cabilly, S., Riggs, A.D., Pande, H., Shively, J.E., Holmes, W.E.,
`Rey, M., Perry, L.J., Wetzel, R. and Heyneker, H.L.: Genera(cid:173)
`tion of antibody activity from immunoglobulin polypeptide
`
`•
`
`REFERENCES
`
`BEQ 1032
`Page 4
`
`

`
`chains produced in E. coli. Proc. Nat!. Acad. Sci. USA 81
`(1984) 3273-3277.
`Dorrington, K.J.: The structural basis for the functional ver(cid:173)
`satility of immunoglobulin G. Can. J. Biochem. 56 (1978)
`1087-1101.
`Horwitz, A.H., Chang, C.P., Better, M., Hellstrom, K.E. and
`Robinson, R.R.: Secretion of functional antibody and Fab
`fragment from yeast cells. Proc. Nat!. Acad. Sci. USA 85
`( 1988) 8678-8682.
`Huston, J.S., Levinson, D., Mudgett-Hunter, M., Tai, M.,
`Novotny, J., Margolies, M.N., Ridge, R.I., Bruccolery, R.E.,
`Haber, E., Crea, R. and Oppermann, H.: Protein engineering
`of antibody binding sites: Recovery of specific activity in an
`anti-digoxin single chain Fv analogue produced in E. coli.
`Proc. Nat!. Acad. Sci. USA 85 (1988) 5879-5883.
`Johnson, A. and Thorpe, R.: Immunochemistry in Practice.
`Blackwell Scientific Publications, London, 1982.
`
`557
`
`Kane, J.F. and Hartley, D.L.: Formation of recombinant protein
`inclusion bodies in E. coli. Trends Biotechnol. 6 (1988)
`95-101.
`Leary, J.J., Brigati, D.J. and Ward, D.C.: Rapid and sensitive
`colorimetric method for visualising biotin-labeled DNA
`probes hybridized to DNA or RNA immobilized on nitro(cid:173)
`cellulose: bio-blots. Proc. Nat!. Acad. Sci. USA 80 (1983)
`4045-4049.
`Neuberger, M.S., Williams, G.T. and Fox, R.O.: Recombinant
`antibodies possessing novel effector functions. Nature 312
`( 1984) 604-608.
`Pollitt, S. and Zalkin, H.: Role of primary structure and disulfide
`bond formation in P-lactamase secretion. J. Bacteriol. 153
`(1983) 27-32.
`Skerra, A. and Fluckthun, A.: Assembly of a functional immuno(cid:173)
`globulin F Jragment in E. coli. Science 240 ( 1988) 1038-1040.
`
`BEQ 1032
`Page 5

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket